MRC: Pre-announcement: funding for early stage development of new healthcare interventions

04/05/2023

12/07/2023

Apply for funding to the Developmental Pathway Gap Fund (DPGF), to generate critical preliminary data to build confidence in the development strategy for a new medicine, repurposed medicine, medical device, diagnostic test, or other medical intervention development. The idea for a new product that can improve human health should have already been conceived and supported by other funding. This should be utilised to produce the critical preliminary data needed to support the onward development of the product. The Gap fund sits beyond the smaller and shorter Impact Accelerator funding and before the substantive and longer Developmental Pathway Funding Scheme. Award range: £50,000 - £300,000.

You can apply for academically led translational projects that aim to undertake a focused package of work that will bridge the gap between inception of a new idea and substantive funding through schemes such as the MRC Developmental Pathway Funding Scheme to: - help prevent disease - help improve speed and accuracy of diagnosis of disease - develop new treatments of disease - help to improve outcome monitoring of patients receiving treatment - help to improve the management of diseases and conditions. All human diseases and medical interventions are eligible for support, both in the context of UK healthcare and addressing global health issues.

You should be a researcher employed at an eligible research organisation. These include: - higher education institutions - UK Research and Innovation-approved independent research organisations or NHS bodies - government-funded organisations - institutes at MRC Harwell, the MRC London Institute of Medical Sciences and the MRC Laboratory of Molecular Biology - MRC units and partnership institutes - institutes and units funded by other research councils - public sector research establishments.